Kohzoh Imai

25.2k total citations · 3 hit papers
434 papers, 18.8k citations indexed

About

Kohzoh Imai is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kohzoh Imai has authored 434 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 223 papers in Molecular Biology, 113 papers in Oncology and 81 papers in Immunology. Recurrent topics in Kohzoh Imai's work include Glycosylation and Glycoproteins Research (58 papers), Monoclonal and Polyclonal Antibodies Research (58 papers) and Epigenetics and DNA Methylation (46 papers). Kohzoh Imai is often cited by papers focused on Glycosylation and Glycoproteins Research (58 papers), Monoclonal and Polyclonal Antibodies Research (58 papers) and Epigenetics and DNA Methylation (46 papers). Kohzoh Imai collaborates with scholars based in Japan, United States and United Kingdom. Kohzoh Imai's co-authors include Hiroyuki Yamamoto, Yasuhisa Shinomura, Minoru Toyota, Yuji Hinoda, Hiromu Suzuki, Takashi Tokino, Akinori Takaoka, Fumio Itoh, Yasushi Sasaki and Masaaki Adachi and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kohzoh Imai

428 papers receiving 18.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer

2004 858 citations Hiromu Suzuki, Kornel E. Schuebel et al. profile →
Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence

2003 704 citations Akinori Takaoka, Kohzoh Imai et al. profile →
Comparing antibody and small-molecule therapies for cancer

2006 590 citations Kohzoh Imai, Akinori Takaoka profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kohzoh Imai Japan	75	10.5k	5.4k	3.4k	3.4k	2.6k	434	18.8k
Lalage M. Wakefield United States	64	13.6k 1.3×	6.9k 1.3×	1.8k 0.5×	3.3k 1.0×	3.3k 1.3×	150	23.2k
Michael Zeisberg Germany	55	10.6k 1.0×	5.6k 1.0×	2.9k 0.8×	3.6k 1.1×	2.1k 0.8×	105	21.1k
Ib Jarle Christensen Denmark	61	5.4k 0.5×	5.6k 1.0×	1.9k 0.6×	4.0k 1.2×	2.5k 1.0×	446	15.3k
Masashi Fukayama Japan	78	8.4k 0.8×	8.3k 1.6×	5.8k 1.7×	3.5k 1.0×	2.2k 0.8×	615	24.1k
Luigi Terracciano Switzerland	86	9.2k 0.9×	8.7k 1.6×	4.1k 1.2×	4.4k 1.3×	3.6k 1.4×	565	26.2k
Andres J. Klein–Szanto United States	83	12.0k 1.1×	7.0k 1.3×	1.9k 0.6×	4.9k 1.4×	1.7k 0.7×	383	21.3k
Kathleen R. Cho United States	66	10.5k 1.0×	6.3k 1.2×	1.6k 0.5×	4.8k 1.4×	2.0k 0.8×	152	18.8k
Jennifer R. Grandis United States	75	10.6k 1.0×	10.5k 2.0×	3.1k 0.9×	4.1k 1.2×	2.6k 1.0×	342	23.4k
Dontscho Kerjaschki Austria	79	8.4k 0.8×	6.7k 1.3×	3.7k 1.1×	1.2k 0.3×	3.6k 1.4×	225	21.3k
James D. Griffin United States	95	12.8k 1.2×	7.4k 1.4×	1.4k 0.4×	1.9k 0.6×	5.3k 2.0×	354	29.7k

Countries citing papers authored by Kohzoh Imai

Since Specialization

Citations

This map shows the geographic impact of Kohzoh Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohzoh Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohzoh Imai more than expected).

Fields of papers citing papers by Kohzoh Imai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kohzoh Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohzoh Imai. The network helps show where Kohzoh Imai may publish in the future.

Co-authorship network of co-authors of Kohzoh Imai

This figure shows the co-authorship network connecting the top 25 collaborators of Kohzoh Imai. A scholar is included among the top collaborators of Kohzoh Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohzoh Imai. Kohzoh Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suzuki, Ryo, Eiichiro Yamamoto, Masanori Nojima, et al.. (2013). Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk. Journal of Gastroenterology. 49(7). 1135–1144. 46 indexed citations

Takamaru, Hiroyuki, Eiichiro Yamamoto, Hiromu Suzuki, et al.. (2012). Aberrant Methylation of RASGRF1 Is Associated with an Epigenetic Field Defect and Increased Risk of Gastric Cancer. Cancer Prevention Research. 5(10). 1203–1212. 32 indexed citations

Suzuki, Hiromu, Hirofumi Akashi, Eiichiro Yamamoto, et al.. (2011). Genome-wide Profiling of Chromatin Signatures Reveals Epigenetic Regulation of MicroRNA Genes in Colorectal Cancer. Cancer Research. 71(17). 5646–5658. 135 indexed citations

Igarashi, Shinichi, Hiromu Suzuki, Takeshi Niinuma, et al.. (2010). A Novel Correlation between LINE-1 Hypomethylation and the Malignancy of Gastrointestinal Stromal Tumors. Clinical Cancer Research. 16(21). 5114–5123. 75 indexed citations

Tanaka, Hiroki, Yoshiaki Arimura, Akira Gotō, et al.. (2010). Myogenic lineage differentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat. Journal of Gastroenterology. 46(2). 143–152. 36 indexed citations

Nojima, Masanori, Reo Maruyama, Hiroshi Yasui, et al.. (2009). Genomic Screening for Genes Silenced by DNA Methylation Revealed an Association between RASD1 Inactivation and Dexamethasone Resistance in Multiple Myeloma. Clinical Cancer Research. 15(13). 4356–4364. 53 indexed citations

Idogawa, Masashi, Yasushi Sasaki, Hiromu Suzuki, et al.. (2009). A Single Recombinant Adenovirus Expressing p53 and p21-targeting Artificial microRNAs Efficiently Induces Apoptosis in Human Cancer Cells. Clinical Cancer Research. 15(11). 3725–3732. 54 indexed citations

Taniguchi, Hiroaki, Agustín F. Fernández, Fernando Setién, et al.. (2009). Epigenetic Inactivation of the Circadian Clock Gene BMAL1 in Hematologic Malignancies. Cancer Research. 69(21). 8447–8454. 146 indexed citations

Toyota, Minoru, Hiromu Suzuki, Yasushi Sasaki, et al.. (2008). Epigenetic Silencing of MicroRNA-34b/c and B-Cell Translocation Gene 4 Is Associated with CpG Island Methylation in Colorectal Cancer. Cancer Research. 68(11). 4123–4132. 497 indexed citations

10.

Ting, Angela H., Hiromu Suzuki, Leslie Cope, et al.. (2008). A Requirement for DICER to Maintain Full Promoter CpG Island Hypermethylation in Human Cancer Cells. Cancer Research. 68(8). 2570–2575. 41 indexed citations

11.

Nosho, Katsuhiko, Hiroyuki Yamamoto, Taiga Takahashi, et al.. (2008). Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma. Human Pathology. 39(5). 767–775. 9 indexed citations

12.

Nishikawa, Noriko, Minoru Toyota, Hiromu Suzuki, et al.. (2007). Gene Amplification and Overexpression of PRDM14 in Breast Cancers. Cancer Research. 67(20). 9649–9657. 90 indexed citations

13.

Idogawa, Masashi, Mitsuko Masutani, Miki Shitashige, et al.. (2007). Ku70 and Poly(ADP-Ribose) Polymerase-1 Competitively Regulate β-Catenin and T-Cell Factor-4–Mediated Gene Transactivation: Possible Linkage of DNA Damage Recognition and Wnt Signaling. Cancer Research. 67(3). 911–918. 62 indexed citations

14.

Kametani, Yoshie, Masashi Shiina, Ikumi Katano, et al.. (2006). Development of human–human hybridoma from anti-Her-2 peptide–producing B cells in immunized NOG mouse. Experimental Hematology. 34(9). 1239–1247. 26 indexed citations

15.

Maruyama, Reo, Fumio Aoki, Minoru Toyota, et al.. (2006). Comparative Genome Analysis Identifies the Vitamin D Receptor Gene as a Direct Target of p53-Mediated Transcriptional Activation. Cancer Research. 66(9). 4574–4583. 86 indexed citations

16.

Alazzouzi, Hafid, Verónica Dávalos, Antti Kokko, et al.. (2005). Mechanisms of Inactivation of the Receptor Tyrosine Kinase EPHB2 in Colorectal Tumors. Cancer Research. 65(22). 10170–10173. 75 indexed citations

17.

Naishiro, Yasuyoshi, Tesshi Yamada, Masashi Idogawa, et al.. (2005). Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic β-catenin protein. Oncogene. 24(19). 3141–3153. 40 indexed citations

18.

Horiuchi, Shina, Hiroyuki Yamamoto, Yongfen Min, et al.. (2003). Association of ets‐related transcriptional factor E1AF expression with tumour progression and overexpression of MMP‐1 and matrilysin in human colorectal cancer. The Journal of Pathology. 200(5). 568–576. 71 indexed citations

19.

Yasui, Hiroshi, Masaaki Adachi, & Kohzoh Imai. (2003). Combination of tumor necrosis factor‐α with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice. Cancer. 97(6). 1412–1420. 27 indexed citations

20.

Toyota, Minoru, Yuji Hinoda, Naoaki Nakagawa, et al.. (1996). Gastric antral vascular ectasia causing severe anemia. Journal of Gastroenterology. 31(5). 710–713. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact